Ajax Bay
Guru
- Location
- East Devon
We agree, I think. I said "to increase the gap between first and second doses to 12 weeks (from 3)" was "a 'gamble'!" (Description of risk/gain odds ^^^) Much to gain and the betting slip was cheap: a 'slam dunk' win - hundreds of lives saved; even if effectiveness (against immunological theory/experience) dropped after 3 weeks. Chris Whitty (CMO) said that delaying the second dose was a “public health decision” based on the best advice and balance of risks.Thus, from a scientific viewpoint, the decision to extend the time between doses fourfold was exactly that: a gamble. No data means no evidence!
Edit: Just in: https://www.ndmrb.ox.ac.uk/about/ne...ng-the-3-month-interval-until-the-second-dose
An attraction of the extension to 12 weeks gap 'gamble' is that the JCVI could withdraw that bet quickly and without much vaccination programme friction if evidence emerged of a significant drop-off in effectiveness after 3 (or more) week gap. But from a pure scientific viewpoint, you're dead right: no evidence (narrowness of Pfizer trial design?).
However typifying some of the other examples I gave above (eg procurement haste, acceptance of unknown risk, licensing) as "gambles" or even "Boris's gambles" (presumably with intent to invite pejorative inference as opposed to (PM, government, MHRA or JCVI) reasonable judgement calls) lacks utility. If one wants to cast the 'gamble' net that wide, every decision with uncertain result made by every government, indeed every individual, could be described as a gamble.
I don't discount that the 'gamble' will be extended (ie to more than 12 weeks) as evidence is gathered of immunological levels enduring. However the potential gain is probably not worth the various types of cost. By the time the first of the 12 week gap second doses are due (about 14 Mar) JCVI Groups 1-7 (ie all over 60 and CEV) will have had a first jab.
Last edited: